Human Titin N-Fragment (Serum) ELISA
- Regulatory Status
- RUO
- Incubation time
- overnight, 1 x 1h, 1 x 30min
- Kit size
- 12 x 8
- Specimen / Volumes
- 100 µL serum
- Standard range
- 46.88 - 3000 pmol/L
- Substrate / isotope
- TMB 450 nm
| instructions for use |
|---|
| instructions for use |
|---|
It is one of sarcomere structured protein that is a minimum unit of myofibrillary protein and it has a role as an elastic protein for recovering the length of shortened sarcomere by its contraction. It has been known that titin is cleaved by protein metabolic enzymes such as calpain and matrix metalloprotease if muscles are damaged.
Actually, massive titin degradation was observed in the skeletal muscle of patients with muscular dystrophy, and the presence of various titin fragments in the blood and urine was confirmed. In particular, it has been reported that the approximately 26 kDa N-fragment on the N-terminal region and the approximately 12 kDa C-fragment on the C-terminal region found in urine are increased in patients with various muscle diseases including muscular dystrophy.
This kit is a sandwich ELISA with a combination of two antibodies against titin N-fragments. A titin fragment containing N-terminal region in human serum can be measured.
Titin is the largest protein (3800kDa) in the human body and is found in muscle cells. It acts like a spring, helping muscles stretch and then return to their normal shape. Titin is the biggest known protein in the human body and plays a key role in making muscles strong and flexible.
Loss of muscle mass and function (sarcopenia) is one of the major drivers of frailty and loss of independence during aging. Titin N-Fragment is an emerging biomarker of muscle degradation that enables early assessment and monitoring of muscle health.
Titin N-Fragment can be measured in urine or serum as a biomarker of interest in research related to muscle protein turnover and skeletal muscle biology.
Sarcopenia, frailty and muscle decline are active areas of scientific research, with studies investigating factors such as nutrition and physical activity.
Urine and serum-based assays provide laboratories with tools for the quantitative measurement of Titin N-Fragment. The Titin N-Fragment ELISAs are used for the analysis of muscle-related biomarkers in urine and serum samples.
Sarcopenia and frailty are not inevitable. Evidence highlights the preventive impact of a protein-rich diet, vitamin D and targeted exercise[1][2].
For concrete data please consult the Instruction for Use in the download box on the top right side.
1. Kakehi, S., Wakabayashi, H., Inuma, H., Inose, T., Shioya, M., Aoyama, Y., Hara, T., Uchimura, K., Tomita, K., Okamoto, M., Yoshida, M., Yokota, S., & Suzuki, H. (2022). Rehabilitation Nutrition and Exercise Therapy for Sarcopenia. The world journal of men’s health, 40(1), 1–10. https://doi.org/10.5534/wjmh.200190
2. Yamaguchi, S., Suzuki, K., Inami, T., Kanda, K., Hanye, Z., & Okada, J. (2020). Changes in urinary titin N-terminal fragment concentration after concentric and eccentric exercise. Journal of Sports Science & Medicine, 19(1), 121.
Attenuated titin protein expression is associated with advanced stages of ovarian cancer. Sharma H et al. Mol Ther Oncol. 2025 Jan 14;33(1):200932.
Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies. Nambu Y et al. Front Neurol. 2025 Jul 9:16:1591748.
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
At Tecan, we are driven to improve people’s lives and health.